Zelquistinel clinical trials
Also written AGN-241751 and GATE-251.
How each study uses zelquistinel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the zelquistinel studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2018 | 2 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Syndeio Biosciences, Inc (5)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test zelquistinel.
- Sep 2027Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive DisorderPhase 2 · Syndeio Biosciences, Inc
Studies
Open first, then newest update. How each study uses zelquistinel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive DisorderRecruitingPhase 2Syndeio Biosciences, IncNCT06547489Written as Zelquistinel
- A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive DisorderRecruitingPhase 2Syndeio Biosciences, IncNCT07115329Written as Zelquistinel
- Zelquistinel in the Treatment of Major Depressive DisorderCompletedPhase 2Syndeio Biosciences, IncNCT03586427Written as AGN-241751
- Zelquistinel in the Treatment of Adults With Major Depressive DisorderCompletedPhase 1/2Syndeio Biosciences, IncNCT03726658Written as AGN-241751
- Safety and Tolerability of Zelquistinel in Normal Human VolunteersCompletedPhase 1Syndeio Biosciences, IncNCT04981561Written as zelquistinel
As the comparator · 1 — what is tested is compared with zelquistinel
Codes
What other systems call zelquistinel · ClinicalTrials.gg INT014619
- UNII (FDA) 387WYR6N95ZELQUISTINELConfirmed FDA, Wikidata
- Wikidata Q55602940zelquistinelConfirmed FDA, Wikidata
- NCI Thesaurus C171667ZelquistinelOne source FDA
- DrugBank DB19336One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 387WYR6N95 | ZELQUISTINEL | Confirmed FDA, Wikidata |
| Wikidata | Q55602940 | zelquistinel | Confirmed FDA, Wikidata |
| NCI Thesaurus | C171667 | Zelquistinel | One source FDA |
| DrugBank | DB19336 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.